• FirefoxTry Yahoo Finance on Firefox »
  •  Dow down 0.35% Nasdaq down 0.81%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
     Dow down 0.35% Nasdaq down 0.81%
    {"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

    Quote Results

    Add Quotes

    SymbolTime & PriceChg & % ChgMore Info
    Aug 24 62.73 -0.85 -1.34% Chart, News, Stats, Options, Board
    No such ticker symbol: REAL-TIMETry Symbol Lookup
    {"s" : "mrk","k" : "t53,l84,c63,p43,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

    Quotes delayed, except where indicated otherwise.

    Recent News

    day and time symbols news headline and source
    Wednesday August 24, 2016
    Merck Offers Value and Steady Dividend Growth Gurufocus04:53pm EDT
    Health-care sector trails broader market as pricing issues reinflamed at MarketWatch03:42pm EDT
    11:27 am Merck expands clinical program with Biothera evaluating Keytruda in combo with Imprime PPG, terms were not disclosed Briefing.com11:27am EDT
    Tuesday August 23, 2016
    Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors at TheStreet09:50am EDT
    [$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal12:09am EDT
    Monday August 22, 2016
    Monday links: work and drudgery Yahoo Finance Contributors12:36pm EDT
    [$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal12:22pm EDT
    Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion at Investor's Business Daily09:53am EDT
    Sunday August 21, 2016
    Curbing Excessive Exuberance May be Premature Yahoo Finance Contributors12:33pm EDT
    Thursday August 18, 2016
    How Much Medivation Can Really Fetch in a Buyout at 24/7 Wall St.12:50pm EDT
    2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now at Motley Fool11:38am EDT
    Wednesday August 17, 2016
    Merck Among Drug Giants Looking To Buy Medivation, Says Report at Investor's Business Daily04:32pm EDT
    Gilead Sciences: Still Dominating Hepatitis C But… at Barrons.com03:24pm EDT
    How Will Merck (MRK) Stock React to Potential Medivation Bid? at TheStreet01:51pm EDT
    How Did Merck’s Animal Health Segment Perform? at Market Realist09:04am EDT
    Lux Research Names Mike Coyne as New CEO Marketwired07:30am EDT
    Tuesday August 16, 2016
    Pfizer's Bold Bid to Conquer Cancer at Motley Fool04:26pm EDT
    Remicade Is Driving Down Merck’s Immunology Franchise at Market Realist11:04am EDT
    Mirror Image: Bristol-Myers Loss Is Merck's Potential Gain Benzinga10:11am EDT
    Why Gardasil Is So Important to Merck’s Vaccines Business at Market Realist09:05am EDT
    Monday August 15, 2016
    Merck cutting 148 Montco jobs at American City Business Journals07:50pm EDT
    Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis at 24/7 Wall St.01:05pm EDT